TKPHF:OTCMKTS
Takeda Pharmaceutical Co Ltd
33,85Â US$
0,00%
(0,00) 1K
6-okt, 11:51:40 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoTKPHF tikeri uchun statistika yaratilmoqda...
Bozor kapitali
59,62Â mlrd
Oʻrtacha hajm
2,49Â ming
Hajmi
0,00
52 haftalik eng yuqori
39,20Â US$
52 haftalik eng past
26,33Â US$
Beta
-2,60
Muomaladagi aksiyalar
1,60Â mlrd
Xodimlar soni
47Â ming
Bozor kapitali
59,62Â mlrd
Oʻrtacha hajm
2,49Â ming
Hajmi
0,00
52 haftalik eng yuqori
39,20Â US$
52 haftalik eng past
26,33Â US$
Beta
-2,60
Muomaladagi aksiyalar
1,60Â mlrd
Xodimlar soni
47Â ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
ad-hoc-news.de
·
1 oy oldin
Takeda Pharmaceutical stock trades at EUR 16.55 with a P/ E of 52.1
Profil
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". Wikipedia
Takeda Pharmaceutical Co Ltd haqida
CEOChristophe Weber | Christophe Weber
Xodimlar soni47Â ming
Asos solingan12-iyn, 1781
Bosh ofislar-
Sektor-
Veb-sayttakeda.com